Journal
HEART
Volume 106, Issue 22, Pages 1712-1718Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/heartjnl-2019-315183
Keywords
-
Categories
Funding
- Wellcome Trust Clinical Research Career Development Fellowship [211100/Z/18/Z]
- National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC)
- Cambridge British Heart Foundation (BHF) Centre for Research Excellence
- NIHR Cambridge BRC
- BHF
- Higher Education Funding Council for England
- Engineering and Physical Sciences Research Council
- Wellcome Trust
- Wellcome Trust [211100/Z/18/Z] Funding Source: Wellcome Trust
- EPSRC [EP/N014588/1] Funding Source: UKRI
Ask authors/readers for more resources
Positron emission tomography (PET) imaging is useful in cardiovascular disease across several areas, from assessment of myocardial perfusion and viability, to highlighting atherosclerotic plaque activity and measuring the extent of cardiac innervation in heart failure. Other important roles of PET have emerged in prosthetic valve endocarditis, implanted device infection, infiltrative cardiomyopathies, aortic stenosis and cardio-oncology. Advances in scanner technology, including hybrid PET/MRI and total body PET imaging, as well as the development of novel PET tracers and cardiac-specific postprocessing techniques using artificial intelligence will undoubtedly continue to progress the field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available